| Autor: |
Wood DM; Department of Preclinical Science, XOMA Corporation, Berkeley, California., Parent JB, Gazzano-Santoro H, Lim E, Pruyne PT, Watkins JM, Spoor ES, Reardan DT, Trown PW, Conlon PJ |
| Jazyk: |
angličtina |
| Zdroj: |
Circulatory shock [Circ Shock] 1992 Sep; Vol. 38 (1), pp. 55-62. |
| Abstrakt: |
The murine IgM monoclonal antibody (mAb) E5 was produced by a hybridoma derived from spleen cells of a mouse immunized with the J5 rough mutant of Escherichia coli O111:B4. In a multicenter randomized placebo-controlled clinical trial, E5 has been shown to reduce significantly the mortality and morbidity of patients with Gram-negative sepsis. The characteristics of E5 binding to endotoxin were studied in vitro. We report here the results of binding to an extensive panel of rough lipopolysaccharide (LPS) and lipid A preparations. Using standard immunologic techniques, including enzyme-linked immunosorbent assay (ELISA) and radioimmunoassay (RIA), as well as an antibody capture assay using immobilized antibody and a chromogenic Limulus amebocyte lysate (LAL) detection system, E5 was shown to bind to all rough LPS (chemotypes Ra through Re from Salmonella minnesota and E. coli J5) and lipid A preparations tested. E5 displayed a Kd for Ra LPS of approximately 6.5 nM. These results confirm and extend those reported previously and provide evidence that E5 binds specifically to lipid A and to the lipid A moiety of rough LPS. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
